The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
The RASSF proteins in cancer; from epigenetic silencing to functional characterization
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Minden, A., Lin, A., Claret, F.-X., Abo, A., & Karin, M. (1995) · Cell · doi:10.1016/s0092-8674(05)80019-4 · Cited by 1,478
Promoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Self-citationMBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
Ng, H.-H., Zhang, Y., Hendrich, B., Johnson, C. A., Turner, B. M., Erdjument-Bromage, H., Tempst, P., Reinberg, D., & Bird, A. (1999) · Nature Genetics · doi:10.1038/12659 · Cited by 936
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
Wade, P. A., Gegonne, A., Jones, P. L., Ballestar, E., Aubry, F., & Wolffe, A. P. (1999) · Nature Genetics · doi:10.1038/12664 · Cited by 811
Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members
Kim, S.-T., Lim, D.-S., Canman, C. E., & Kastan, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37538 · Cited by 810
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway
Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C., & Halder, G. (2003) · Nature Cell Biology · doi:10.1038/ncb1050 · Cited by 747
Apoptosis: a basic biological phenomenon with wide‐ranging implications in human disease
FADEEL, B., & ORRENIUS, S. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01570.x · Cited by 698
Jones, P. A. (1999) · Trends in Genetics · doi:10.1016/s0168-9525(98)01636-9 · Cited by 665
The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network
Harvey, K., & Tapon, N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2070 · Cited by 628
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208445 · Cited by 584
Downward, J. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80061-0 · Cited by 555
Lerman, M. I., & Minna, J. D. (2000) · PubMed · Cited by 538
Cheng, M., Sexl, V., Sherr, C. J., & Roussel, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1091 · Cited by 496
Katagiri, K., Maeda, A., Shimonaka, M., & Kinashi, T. (2003) · Nature Immunology · doi:10.1038/ni950 · Cited by 461
Donninger, H., Vos, M. D., & Clark, G. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.010389 · Cited by 440
Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zöchbauer‐Müller, S., Farinas, A. J., Vakar‐Lopez, F., Minna, J. D., Sagalowsky, A. I., et al. (2001) · PubMed · Cited by 422
MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation
Praskova, M., Xia, F., & Avruch, J. (2008) · Current Biology · doi:10.1016/j.cub.2008.02.006 · Cited by 422
Matallanas, D., Romano, D., Yee, K., Meissl, K., Kucerova, L., Piazzolla, D., Baccarini, M., Vass, J. K., Kolch, W., & O'Neill, E. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.008 · Cited by 416
Microtubule-organizing centres: a re-evaluation
Lüders, J., & Stearns, T. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2100 · Cited by 395
The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation
Shivakumar, L., Minna, J., Sakamaki, T., Pestell, R., & White, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4309-4318.2002 · Cited by 393
Role of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers
Agathanggelou, A., Cooper, W. N., & Latif, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4088 · Cited by 388
Saucedo, L. J., & Edgar, B. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2221 · Cited by 363
Tenenhaus, C., Subramaniam, K., Dunn, M. A., & Seydoux, G. (2001) · Genes & Development · doi:10.1101/gad.876201 · Cited by 357
Identification of a Novel Ras-Regulated Proapoptotic Pathway
Khokhlatchev, A., Rabizadeh, S., Xavier, R., Nedwidek, M., Chen, T., Zhang, X.-F., Seed, B., & Avruch, J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00683-8 · Cited by 357
Powering membrane traffic in endocytosis and recycling
Soldati, T., & Schliwa, M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2060 · Cited by 346
PRASKOVA, M., KHOKLATCHEV, A., ORTIZ-VEGA, S., & AVRUCH, J. (2004) · Biochemical Journal · doi:10.1042/bj20040025 · Cited by 342
Rodriguez-Viciana, P., Sabatier, C., & McCormick, F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4943-4954.2004 · Cited by 327 · cited 4×
“Overexpression of RASSF1C with members of the RAS-family showed an interaction with RRAS3/ M-RAS and a weak interaction with NRAS and KRAS [106].”
BackgroundInfluentialThe tumour suppressor RASSF1A regulates mitosis by inhibiting the APC–Cdc20 complex
Song, M. S., Song, S. J., Ayad, N. G., Chang, J. S., Lee, J. H., Hong, H. K., Lee, H., Choi, N., Kim, J., Kim, H., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1091 · Cited by 311
Riemenschneider, M. J., Büschges, R., Wolter, M., REIFENBERGER, J., Boström, J. P., Kraus, J. A., Schlegel, U. S., & Reifenberger, G. (1999) · PubMed · Cited by 297
Dreijerink, K., Braga, E., Kuzmin, I., Geil, L., Duh, F.-M., Angeloni, D., Zbar, B., Lerman, M. I., Stanbridge, E. J., Minna, J. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131216298 · Cited by 294
Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis
Vos, M. D., Ellis, C. A., Bell, A., Birrer, M. J., & Clark, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000463200 · Cited by 289
The Ras-association domain family (RASSF) members and their role in human tumourigenesis
van der Weyden, L., & Adams, D. J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.06.003 · Cited by 284
Holliday, R. (1994) · Developmental Genetics · doi:10.1002/dvg.1020150602 · Cited by 272
Osborne, C., Wilson, P., & Tripathy, D. (2004) · The Oncologist · doi:10.1634/theoncologist.9-4-361 · Cited by 257
Katagiri, K., Imamura, M., & Kinashi, T. (2006) · Nature Immunology · doi:10.1038/ni1374 · Cited by 230
Ried, T., Just, K., Holtgreve-Grez, H., du Manoir, S., Speicher, M. R., Schröck, E., Latham, C., Blegen, H., Zetterberg, A., & Cremer, T. (1995) · PubMed · Cited by 229
Role of JNK in Tumor Development
(2003) · Cell Cycle · doi:10.4161/cc.2.3.388 · Cited by 225
Tumor Susceptibility of Rassf1a Knockout Mice
Tommasi, S., Dammann, R., Zhang, Z., Wang, Y., Liu, L., Tsark, W. M., Wilczynski, S. P., Li, J., You, M., & Pfeifer, G. P. (2005) · Cancer Research · doi:10.1158/0008-5472.92.65.1 · Cited by 214
Self-citationOrtiz-Vega, S., Khokhlatchev, A., Nedwidek, M., Zhang, X.-F., Dammann, R., Pfeifer, G. P., & Avruch, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205192 · Cited by 209
Self-citationIdentification of Nore1 as a Potential Ras Effector
Vavvas, D., Li, X., Avruch, J., & Zhang, X.-F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5439 · Cited by 208
A novel family ofras-binding domains
Ponting, C. P., & Benjamin, D. R. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)30038-8 · Cited by 205
RASSF1A Is Part of a Complex Similar to the Drosophila Hippo/Salvador/Lats Tumor-Suppressor Network
Guo, C., Tommasi, S., Liu, L., Yee, J.-K., Dammann, R., & Pfeifer, G. P. (2007) · Current Biology · doi:10.1016/j.cub.2007.02.055 · Cited by 200
Self-citationThe tumor suppressor RASSF1A in human carcinogenesis: an update.
Dammann, R., Schagdarsurengin, U., Seidel, C., Strunnikova, M., Rastetter, M., Baier, K., & Pfeifer, G. P. (2005) · PubMed · doi:10.14670/hh-20.645 · Cited by 197
Self-citationRole of the Tumor Suppressor RASSF1A in Mst1-Mediated Apoptosis
Oh, H. J., Lee, K.-K., Song, S. J., Jin, M. S., Song, M. S., Lee, J. H., Im, C. R., Lee, J.-O., Yonehara, S., & Lim, D.-S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2951 · Cited by 196
Control of microtubule stability by the RASSF1A tumor suppressor
Liu, L., Tommasi, S., Lee, D.-H., Dammann, R., & Pfeifer, G. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206984 · Cited by 193
Self-citationProtein Kinase C: Seeing two domains
Newton, A. C. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00191-6 · Cited by 187
Baksh, S., Tommasi, S., Fenton, S., Yu, V. C., Martins, L. M., Pfeifer, G. P., Latif, F., Downward, J., & Neel, B. G. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.05.010 · Cited by 186
Self-citationRASSF2 Is a Novel K-Ras-specific Effector and Potential Tumor Suppressor
Vos, M. D., Ellis, C. A., Elam, C., Ülkü, A. S., Taylor, B. J., & Clark, G. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300554200 · Cited by 183
K-ras mutations and RASSF1A promoter methylation in colorectal cancer
van Engeland, M., Roemen, G. M., Brink, M., Pachen, M. M., Weijenberg, M. P., de Bruïne, A. P., Arends, J.-W., van den Brandt, P. A., FPM de Goeij, A., & Herman, J. G. (2002) · Oncogene · doi:10.1038/sj.onc.1205466 · Cited by 181
Recognizing and Defining True Ras Binding Domains I: Biochemical Analysis
Wohlgemuth, S., Kiel, C., Krämer, A., Serrano, L., Wittinghofer, F., & Herrmann, C. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.02.048 · Cited by 177
Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma
Dammann, R., Schagdarsurengin, U., Liu, L., Otto, N., Gimm, O., Dralle, H., Boehm, B. O., Pfeifer, G. P., & Hoang-Vu, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206582 · Cited by 173
Self-citationEvaluation of the 3p21.3 tumour-suppressor gene cluster
Hesson, L. B., Cooper, W. N., & Latif, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210547 · Cited by 161
Vos, M. D., Martinez, A., Elam, C., Dallol, A., Taylor, B. J., Latif, F., & Clark, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0339 · Cited by 159
Kuzmin, I., Gillespie, J. W., Protopopov, A. I., Geil, L., Dreijerink, K. M. A., Yang, Y., Vocke, C. D., Duh, F.-M. C., Zabarovsky, E. R., Minna, J. D., et al. (2002) · PubMed · Cited by 158
The Drosophila RASSF Homolog Antagonizes the Hippo Pathway
Polesello, C., Huelsmann, S., Brown, N. H., & Tapon, N. (2006) · Current Biology · doi:10.1016/j.cub.2006.10.060 · Cited by 151
Tenenhaus, C. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/9024-dx23 · Cited by 150
The Ras Effector RASSF2 Is a Novel Tumor-Suppressor Gene in Human Colorectal Cancer
Akino, K., Toyota, M., Suzuki, H., Mita, H., Sasaki, Y., Ohe-Toyota, M., Issa, J. J., Hinoda, Y., Imai, K., & Tokino, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.051 · Cited by 148
RASSF6 is a novel member of the RASSF family of tumor suppressors
Allen, N. P. C., Donninger, H., Vos, M. D., Eckfeld, K., Hesson, L. B., Gordon, L. E., Birrer, M. J., Latif, F., & Clark, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210440 · Cited by 146
RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics
Dallol, A., Agathanggelou, A., Fenton, S. L., Ahmed-Choudhury, J., Hesson, L. B., Vos, M. D., Clark, G., Downward, J., Maher, E. R., & Latif, F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0267 · Cited by 146
The RASSF1A Tumor Suppressor Activates Bax via MOAP-1
Vos, M. D., Dallol, A., Eckfeld, K., Allen, N. P. C., Donninger, H., Hesson, L. B., Calvisi, D. F., Latif, F., & Clark, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m512128200 · Cited by 143
Dammann, R., Schagdarsurengin, U., Strunnikova, M., Rastetter, M., Seidel, C., Liu, L., Tommasi, S., & Pfeifer, G. P. (2003) · PubMed · doi:10.14670/hh-18.665 · Cited by 139
Self-citationFrequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee, M., Kim, H. Y., Byun, D.-S., Lee, S., Lee, C. H., Kim, J. I., Chang, S., & Chi, S. G. (2001) · PubMed · Cited by 134
NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers
Hesson, L. B., Dallol, A., Minna, J. D., Maher, E. R., & Latif, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206191 · Cited by 130
Hesson, L. B., Bièche, I., Krex, D., Crinière, E., Hoang‐Xuan, K., Maher, E. R., & Latif, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207407 · Cited by 128
Hwang, E., Ryu, K., Pääkkönen, K., Güntert, P., Cheong, H., Lim, D., Lee, J., Jeon, Y. H., & Cheong, C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610716104 · Cited by 127
The Pro-apoptotic Ras Effector Nore1 May Serve as a Ras-regulated Tumor Suppressor in the Lung
Vos, M. D., Martínez, A., Ellis, C. A., Vallecorsa, T., & Clark, G. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211019200 · Cited by 125
A novel inter action motif, SARAH, connects three classes of tumor suppressor
Scheel, H., & Hofmann, K. (2003) · Current Biology · doi:10.1016/j.cub.2003.11.007 · Cited by 124
RASSF4/AD037 Is a Potential Ras Effector/Tumor Suppressor of the RASSF Family
Eckfeld, K., Hesson, L. B., Vos, M. D., Bièche, I., Latif, F., & Clark, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2065 · Cited by 120
RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors
Nakamura, N., Carney, J. A., Jin, L. G., Kajita, S., Pallarés, J., Zhang, H., Qian, X., Sebo, T. J., Erickson, L. A., & Lloyd, R. V. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700306 · Cited by 119
Microtubule-associated protein 1B, a growth-associated and phosphorylated scaffold protein
Riederer, B. M. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.11.012 · Cited by 116
Tommasi, S., Dammann, R., Jin, S., Zhang, X., Avruch, J., & Pfeifer, G. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205365 · Cited by 115
Self-citationKatagiri, K., Shimonaka, M., & Kinashi, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310717200 · Cited by 114
Chen, J., Lui, W., Vos, M. D., Clark, G. J., Takahashi, M., Schoumans, J., Khoo, S. K., Petillo, D., Lavery, T. T., Sugimura, J., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00269-1 · Cited by 114
Liu, L., Broaddus, R. R., Yao, J. C., Xie, S.-S., White, J. A., Wu, T., Hamilton, S. R., & Rashid, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800490 · Cited by 112
Armesilla, A. L., Williams, J. C., Buch, M. H., Pickard, A., Emerson, M., Cartwright, E. J., Oceandy, D., Vos, M. D., Gillies, S., Clark, G. J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307557200 · Cited by 111
Takahashi, T., Shivapurkar, N., Riquelme, E. M., Shigematsu, H., Reddy, J., Suzuki, M., Miyajima, K., Zhou, X. C., Bekele, B. N., Gazdar, A. F., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0579 · Cited by 110
Kiel, C., Wohlgemuth, S., Rousseau, F., Schymkowitz, J. W. H., Ferkinghoff‐Borg, J., Wittinghofer, F., & Serrano, L. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.02.046 · Cited by 102
Rong, R., Jin, W., Zhang, J., Sheikh, M. S., & Huang, Y. K. (2004) · Oncogene · doi:10.1038/sj.onc.1207901 · Cited by 102
Gene Expression Patterns in Pancreatic Tumors, Cells and Tissues
Lowe, A. W., Olsen, M. N., Hao, Y., Lee, S. P., Lee, K. T., Chen, X., van de Rijn, M., & Brown, P. O. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000323 · Cited by 100
The RASSF1A Isoform of RASSF1 Promotes Microtubule Stability and Suppresses Tumorigenesis
van der Weyden, L., Tachibana, K.-E. K., Gonzalez, M., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8356-8367.2005 · Cited by 99
Rong, R., Jiang, L., Sheikh, M. S., & Huang, Y. K. (2007) · Oncogene · doi:10.1038/sj.onc.1210575 · Cited by 96
Genome-wide detection of LOH in prostate cancer using human SNP microarray technology
Dumur, C. I., Dechsukhum, C., Ware, J. L., Cofield, S. S., Best, A. M., Wilkinson, D. S., Garrett, C. T., & Ferreira‐Gonzalez, A. (2003) · Genomics · doi:10.1016/s0888-7543(03)00020-x · Cited by 94
Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases
Aoyama, Y., Avruch, J., & Zhang, X. (2004) · Oncogene · doi:10.1038/sj.onc.1207486 · Cited by 94
Rabizadeh, S., Xavier, R. J., Ishiguro, K., Bernabé-Ortiz, J. C., Lopez-Ilasaca, M. A., Khokhlatchev, A. V., Mollahan, P., Pfeifer, G. P., Avruch, J., & Seed, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401699200 · Cited by 93
Self-citationAlam, M. R., Caldwell, B. D., Johnson, R. C., Darlington, D. N., Mains, R. E., & Eipper, B. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.45.28636 · Cited by 90
Dynamics of RASSF1A/MOAP-1 Association with Death Receptors
Foley, C. J., Freedman, H., Choo, S. L., Onyskiw, C., Fu, N. Y., Yu, V. C. K., Tuszyński, J. A., Pratt, J. C., & Baksh, S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02011-07 · Cited by 90
Involvement of the RASSF1A Tumor Suppressor Gene in Controlling Cell Migration
Dallol, A., Agathanggelou, A., Tommasi, S., Pfeifer, G. P., Maher, E. R., & Latif, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0247 · Cited by 89
Self-citationNore1 and RASSF1 Regulation of Cell Proliferation and of the MST1/2 Kinases
Avruch, J., Praskova, M. D., Ortiz-Vega, S., Liu, M., & Zhang, X. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07025-4 · Cited by 86
Ura, S., Nishina, H., Gotoh, Y., & Katada, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00199-07 · Cited by 83
RASSF1A Suppresses the c-Jun-NH2-Kinase Pathway and Inhibits Cell Cycle Progression
Whang, Y. M., Kim, Y. H., Kim, J. S., & Yoo, Y. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2792 · Cited by 82
Ikeda, M., Hirabayashi, S., Fujiwara, N., et al. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.02.013 · Cited by 81
Sherwood, V., Manbodh, R., Sheppard, C., & Chalmers, A. D. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-07-0652 · Cited by 80
Fujita, H., Fukuhara, S., Sakurai, A., Yamagishi, A., Kamioka, Y., Nakaoka, Y., Masuda, M., & Mochizuki, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409701200 · Cited by 76
Ashida, R., Tominaga, K., Sasaki, E., Watanabe, T., Fujiwara, Y., Oshitani, N., Higuchi, K., Mitsuyama, S., Iwao, H., & Arakawa, T. (2005) · Inflammopharmacology · doi:10.1163/156856005774423935 · Cited by 74
Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation
Kitagawa, D., Kajiho, H., Negishi, T., Ura, S., Watanabe‐Asaka, T., Wada, T., Ichijo, H., Katada, T., & Nishina, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601212 · Cited by 74
Zanke, B. W., Squire, J. A., Griesser, H., Henry, M. A., Suzuki, H., Patterson, B. J., Minden, M. D., & Mak, T. W. (1994) · PubMed · Cited by 70
Song, M. S., Chang, J. S., Song, S. J., Yang, T. H., Lee, H., & Lim, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409115200 · Cited by 68
Almeida, A., Zhu, X., Vogt, N., Tyagi, R., Muleris, M., Dutrillaux, A., Dutrillaux, B., Ross, D. A., Malfoy, B., & Hanash, S. (1998) · Oncogene · doi:10.1038/sj.onc.1201828 · Cited by 68
Reu, F. J., Leaman, D. W., Maitra, R. R., Bae, S. I., Cherkassky, L., Fox, M. W., Rempinski, D., Beaulieu, N., MacLeod, A. R., & Borden, E. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2303 · Cited by 65
Quantitative evaluation of RASSF1Amethylation in the non-lesional, regenerative and neoplastic liver
Gioia, S. D., Bianchi, P. P., Destro, A., Grizzi, F., Malesci, A., Laghi, L., Levrero, M., Morabito, A., & Roncalli, M. G. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-89 · Cited by 65
Song, M., Song, S. J., Kim, S., Nakayama, K., Nakayama, K., & Lim, D.-S. (2007) · Oncogene · doi:10.1038/sj.onc.1210971 · Cited by 65
Haplotype mapping of the bronchiolitis susceptibility locus near IL8
Hull, J., Rowlands, K., Lockhart, E., Sharland, M., Moore, C. E., Hanchard, N. A., & Kwiatkowski, D. P. (2004) · Human Genetics · doi:10.1007/s00439-003-1038-x · Cited by 61
Liu, L., Vo, A., & McKeehan, W. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3896 · Cited by 61
Identification of RASSF8 as a candidate lung tumor suppressor gene
Falvella, F. S., Manenti, G., Spinola, M., Pignatiello, C., Conti, B., Pastorino, U., & Dragani, T. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209422 · Cited by 57
Kinashi, T., & Katagiri, K. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02214.x · Cited by 56
Estrabaud, E., Lassot, I., Blot, G., Rouzic, E. L., Tanchou, V., Quéméneur, É., Daviet, L., Margottin-Goguet, F., & Bénarous, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2530 · Cited by 56
Moshnikova, A., Frye, J., Shay, J. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511837200 · Cited by 55
Chen, L., Johnson, R. C., & Milgram, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33524 · Cited by 55
RASSF1A Polymorphism A133S Is Associated with Early Onset Breast Cancer in BRCA1/2 Mutation Carriers
Gao, B., Xie, X., Huang, C., Shames, D. S., Chen, T. T.-L., Lewis, C. M., Bian, A., Zhang, B., Olopade, O. I., Garber, J. E., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5183 · Cited by 53
Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma
Chow, L. S.-N., Lo, K. W., Kwong, J., Wong, A. Y.-H., & Huang, D. P. (2004) · Oncology Reports · doi:10.3892/or.12.4.781 · Cited by 45
Miertzschke, M., Stanley, P., Bunney, T. D., Rodrigues‐Lima, F., Hogg, N., & Katan, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704361200 · Cited by 43
Park, H., Kang, H. C., Kim, I., Jang, S., Kim, K., Yoon, H., Jeong, S., & Park, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.22276 · Cited by 43
Ras association domain family 1C protein stimulates human lung cancer cell proliferation
Amaar, Y. G., Minera, M., Hatran, L. K., Strong, D. D., Mohan, S., & Reeves, M. E. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00072.2006 · Cited by 41
RASSF1A interacts with and activates the mitotic kinase Aurora-A
LIU, L., Guo, C., Dammann, R., Tommasi, S., & Pfeifer, G. P. (2008) · Oncogene · doi:10.1038/onc.2008.220 · Cited by 38
Self-citationLiu, L., Baier, K., Dammann, R., & Pfeifer, G. P. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4435 · Cited by 34
Self-citationKumari, G., Singhal, P. K., Rao, M. R. K. S., & Mahalingam, S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.01.026 · Cited by 34
Kang, S., Lee, J. M., Jeon, E., Lee, S., Kim, H., Kim, H., Seo, S., Park, S., Sidransky, D., & Dong, S. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21991 · Cited by 34
Loss of Rassf1a cooperates with ApcMin to accelerate intestinal tumourigenesis
van der Weyden, L., Arends, M. J., Dovey, O. M., Harrison, H., Lefebvre, G. C., Conte, N., Gergely, F. V., Bradley, A., & Adams, D. J. (2008) · Oncogene · doi:10.1038/onc.2008.94 · Cited by 32
The tumour suppressor RASSF1A is a novel substrate of PKC
Verma, S. K., Ganesan, T. S., & Parker, P. J. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.05.028 · Cited by 24
Wang, X., Di, K., Zhang, X., Han, H., Wong, Y. C., Leung, S. C. L., & Ling, M. (2008) · Oncogene · doi:10.1038/onc.2008.87 · Cited by 23
Reuther, G. W., Buss, J. E., Quilliam, L. A., Clark, G. J., & Der, C. J. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)27288-1 · Cited by 19
Nore1B regulates TCR signaling via Ras and Carma1
Ishiguro, K., Avruch, J., Landry, A. L., Qin, S., Ando, T., Goto, H., & Xavier, R. J. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.01.015 · Cited by 14
Cited by
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
Epithelial cell polarity, stem cells and cancer
Martin-Belmonte, F., & Perez-Moreno, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3169 · Cited by 552
Raf Family Kinases: Old Dogs Have Learned New Tricks
Matallanas, D., Birtwistle, M., Romano, D., Zebisch, A., Rauch, J., von Kriegsheim, A., & Kolch, W. (2011) · Genes & Cancer · doi:10.1177/1947601911407323 · Cited by 386
Metadata
- Authors
- Richter, A. M., Pfeifer, G. P., & Dammann, R. H.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 1796
- Issue
- 2
- Pages
- 114-128
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2149432374
- Cited by
- 295
- References
- 125
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.